THE USE OF RIFAMPICIN IN STAPHYLOCOCCAL INFECTIONS - A REVIEW

被引:23
作者
KAPUSNIK, JE
PARENTI, F
SANDE, MA
机构
[1] SAN FRANCISCO GEN HOSP, SAN FRANCISCO, CA 94110 USA
[2] UNIV CALIF SAN FRANCISCO, SCH PHARM, DIV CLIN PHARMACOL, SAN FRANCISCO, CA 94143 USA
[3] UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA
[4] GRP LEPETIT SPA, RIC LAB, MILAN, ITALY
关键词
D O I
10.1093/jac/13.suppl_C.61
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:61 / 66
页数:6
相关论文
共 27 条
[21]  
VANDERAUWERA P, 1983, REV INFECT DIS, V5, pS515
[22]   ANTAGONISM BETWEEN NAFCILLIN OR OXACILLIN AND RIFAMPIN AGAINST STAPHYLOCOCCUS-AUREUS [J].
WATANAKUNAKORN, C ;
TISONE, JC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (05) :920-922
[23]  
WEHRLI W, 1983, REV INFECT DIS, V5, pS407
[24]  
WHEAT LJ, 1983, REV INFECT DIS, V5, pS459
[25]   EFFECT OF RIFAMPIN ON NASAL CARRIERS OF COAGULASE-POSITIVE STAPHYLOCOCCI [J].
WHEAT, LJ ;
KOHLER, RB ;
WHITE, AL ;
WHITE, A .
JOURNAL OF INFECTIOUS DISEASES, 1981, 144 (02) :177-177
[26]  
ZAK O, 1983, REV INFECT DIS, V5, pS481
[27]  
ZIMMERLI W, 1984, J CLIN INVESTIGATION